Skip to main content

The Asthma and Allergy Foundation of America (AAFA) has joined with the Allergy & Asthma Network, the Center for Science in the Public Interest and Food Allergy Research & Education to issue a statement about the current government shut down and its impact on the Food and Drug Administration's (FDA) review of food allergy therapies:

We are hopeful that the government shutdown will end as soon as possible so that the FDA can get back to work reviewing potential food allergy treatments. It is imperative that any potential treatments are processed through the system quickly, as patients' lives are at stake.

Delays of any kind prolong the long wait for a potentially life-saving therapy for peanut allergy. We hope that our leaders can find a way to reach an agreement and let the FDA continue their work.

(Kids With Food Allergies is a division of AAFA.)

Join our community to follow our blog for the latest news on food allergy research and advocacy. Our community also provides an opportunity to connect with others who manage these conditions for peer support.

JOIN NOW

Tags: FDA, Advocacy

Add Comment

Comments (1)

Newest · Oldest · Popular
β€œDelays of any kind prolong the long wait for a potentially life-saving therapy for peanut allergy.”

Should read for food allergies. Not just specifically for peanut allergy.

Respectfully,
Fred Adler

> On Jan 22, 2019, at 2:28 PM, Kids With Food Allergies <support@aafa.org> wrote:
>
> Delays of any kind prolong the long wait for a potentially life-saving therapy for peanut allergy.
F
×
×
×
Link copied to your clipboard.
×